Peripherally Acting Antiobesity Products

Name
Peripherally Acting Antiobesity Products
Accession Number
DBCAT002499
Description

Not Available

ATC Classification
Drugs
DrugDrug Description
OrlistatA reversible inhibitor of gastrointestinal lipases indicated for weight loss and weight maintenance.
Drugs & Drug Targets
DrugTargetType
OrlistatPancreatic triacylglycerol lipasetarget
OrlistatFatty acid synthasetarget
OrlistatGastric triacylglycerol lipasetarget
OrlistatCytochrome P450 3A4enzyme
OrlistatCytosolic phospholipase A2enzyme
OrlistatSerum albumincarrier
OrlistatFatty acid synthaseenzyme